- FDA advisory committee meeting on Grail's Galleri test is underway Wednesday.
FDA advisory committee meets on Grail's Galleri blood test for multi-cancer early detection. Approval would unlock Medicare and insurance reimbursement, but the test's landmark study missed its goal in June. Analysts expect a constrained label. Panel vote due Wednesday.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.